The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Blood Plasma Products Market Research Report 2024
Synopsis
Plasma, the major component of blood, is vital to the regulation of body functions. Blood plasma consists of several useful components such as albumin, coagulation factors, protease inhibitors and immunoglobulins. Since deficiencies in a component can result in the onset of a disease, both basic and targeted R&D has accelerated in this area. Blood plasma is part of an effective therapeutic treatment plan in various therapies due to its potential in battling several chronic and life-threatening diseases
The global Blood Plasma Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Products.
Report Scope
The Blood Plasma Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Plasma Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Ltd.
Creat Group Corporation
Grifols SA
Takeda
Octapharma AG
Kedrion SpA
Biotest AG
China Biologic Products
Sanquin
LFB S.A.
Segment by Type
Immunoglobulins
Coagulation Factor Concentrates
Other
Segment by Application
Hospitals And Clinics
Research Laboratories
Academic Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Plasma Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Plasma, the major component of blood, is vital to the regulation of body functions. Blood plasma consists of several useful components such as albumin, coagulation factors, protease inhibitors and immunoglobulins. Since deficiencies in a component can result in the onset of a disease, both basic and targeted R&D has accelerated in this area. Blood plasma is part of an effective therapeutic treatment plan in various therapies due to its potential in battling several chronic and life-threatening diseases
The global Blood Plasma Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Products.
Report Scope
The Blood Plasma Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Plasma Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Ltd.
Creat Group Corporation
Grifols SA
Takeda
Octapharma AG
Kedrion SpA
Biotest AG
China Biologic Products
Sanquin
LFB S.A.
Segment by Type
Immunoglobulins
Coagulation Factor Concentrates
Other
Segment by Application
Hospitals And Clinics
Research Laboratories
Academic Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Plasma Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Plasma Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunoglobulins
1.2.3 Coagulation Factor Concentrates
1.2.4 Other
1.3 Market by Application
1.3.1 Global Blood Plasma Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals And Clinics
1.3.3 Research Laboratories
1.3.4 Academic Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Plasma Products Market Perspective (2019-2030)
2.2 Blood Plasma Products Growth Trends by Region
2.2.1 Global Blood Plasma Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Plasma Products Historic Market Size by Region (2019-2024)
2.2.3 Blood Plasma Products Forecasted Market Size by Region (2025-2030)
2.3 Blood Plasma Products Market Dynamics
2.3.1 Blood Plasma Products Industry Trends
2.3.2 Blood Plasma Products Market Drivers
2.3.3 Blood Plasma Products Market Challenges
2.3.4 Blood Plasma Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Plasma Products Players by Revenue
3.1.1 Global Top Blood Plasma Products Players by Revenue (2019-2024)
3.1.2 Global Blood Plasma Products Revenue Market Share by Players (2019-2024)
3.2 Global Blood Plasma Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Plasma Products Revenue
3.4 Global Blood Plasma Products Market Concentration Ratio
3.4.1 Global Blood Plasma Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Products Revenue in 2023
3.5 Blood Plasma Products Key Players Head office and Area Served
3.6 Key Players Blood Plasma Products Product Solution and Service
3.7 Date of Enter into Blood Plasma Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Plasma Products Breakdown Data by Type
4.1 Global Blood Plasma Products Historic Market Size by Type (2019-2024)
4.2 Global Blood Plasma Products Forecasted Market Size by Type (2025-2030)
5 Blood Plasma Products Breakdown Data by Application
5.1 Global Blood Plasma Products Historic Market Size by Application (2019-2024)
5.2 Global Blood Plasma Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Plasma Products Market Size (2019-2030)
6.2 North America Blood Plasma Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Plasma Products Market Size by Country (2019-2024)
6.4 North America Blood Plasma Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Plasma Products Market Size (2019-2030)
7.2 Europe Blood Plasma Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Plasma Products Market Size by Country (2019-2024)
7.4 Europe Blood Plasma Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Products Market Size (2019-2030)
8.2 Asia-Pacific Blood Plasma Products Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Plasma Products Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Plasma Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Plasma Products Market Size (2019-2030)
9.2 Latin America Blood Plasma Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Plasma Products Market Size by Country (2019-2024)
9.4 Latin America Blood Plasma Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Products Market Size (2019-2030)
10.2 Middle East & Africa Blood Plasma Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Plasma Products Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Plasma Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL Ltd.
11.1.1 CSL Ltd. Company Detail
11.1.2 CSL Ltd. Business Overview
11.1.3 CSL Ltd. Blood Plasma Products Introduction
11.1.4 CSL Ltd. Revenue in Blood Plasma Products Business (2019-2024)
11.1.5 CSL Ltd. Recent Development
11.2 Creat Group Corporation
11.2.1 Creat Group Corporation Company Detail
11.2.2 Creat Group Corporation Business Overview
11.2.3 Creat Group Corporation Blood Plasma Products Introduction
11.2.4 Creat Group Corporation Revenue in Blood Plasma Products Business (2019-2024)
11.2.5 Creat Group Corporation Recent Development
11.3 Grifols SA
11.3.1 Grifols SA Company Detail
11.3.2 Grifols SA Business Overview
11.3.3 Grifols SA Blood Plasma Products Introduction
11.3.4 Grifols SA Revenue in Blood Plasma Products Business (2019-2024)
11.3.5 Grifols SA Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Blood Plasma Products Introduction
11.4.4 Takeda Revenue in Blood Plasma Products Business (2019-2024)
11.4.5 Takeda Recent Development
11.5 Octapharma AG
11.5.1 Octapharma AG Company Detail
11.5.2 Octapharma AG Business Overview
11.5.3 Octapharma AG Blood Plasma Products Introduction
11.5.4 Octapharma AG Revenue in Blood Plasma Products Business (2019-2024)
11.5.5 Octapharma AG Recent Development
11.6 Kedrion SpA
11.6.1 Kedrion SpA Company Detail
11.6.2 Kedrion SpA Business Overview
11.6.3 Kedrion SpA Blood Plasma Products Introduction
11.6.4 Kedrion SpA Revenue in Blood Plasma Products Business (2019-2024)
11.6.5 Kedrion SpA Recent Development
11.7 Biotest AG
11.7.1 Biotest AG Company Detail
11.7.2 Biotest AG Business Overview
11.7.3 Biotest AG Blood Plasma Products Introduction
11.7.4 Biotest AG Revenue in Blood Plasma Products Business (2019-2024)
11.7.5 Biotest AG Recent Development
11.8 China Biologic Products
11.8.1 China Biologic Products Company Detail
11.8.2 China Biologic Products Business Overview
11.8.3 China Biologic Products Blood Plasma Products Introduction
11.8.4 China Biologic Products Revenue in Blood Plasma Products Business (2019-2024)
11.8.5 China Biologic Products Recent Development
11.9 Sanquin
11.9.1 Sanquin Company Detail
11.9.2 Sanquin Business Overview
11.9.3 Sanquin Blood Plasma Products Introduction
11.9.4 Sanquin Revenue in Blood Plasma Products Business (2019-2024)
11.9.5 Sanquin Recent Development
11.10 LFB S.A.
11.10.1 LFB S.A. Company Detail
11.10.2 LFB S.A. Business Overview
11.10.3 LFB S.A. Blood Plasma Products Introduction
11.10.4 LFB S.A. Revenue in Blood Plasma Products Business (2019-2024)
11.10.5 LFB S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
